ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Novaliq Logo

Novaliq

Novaliq is a pharmaceutical company committed to develop best-in-class ocular therapies.Our unique and versatile water-free technology is poised to transform established treatments. Novaliq is headquartered in Heidelberg, Germany and has an office in Cambridge, MA, USA. EyeSol®, Novaliq’s unique and proprietary water-free technology, opens completely new and intriguing opportunities to cure, relief and prevent diseases in various areas of indications for patients. Since December 2019, Novaliq has a strategic cooperation with Bausch + Lomb. In China, Novaliq has a strategic cooperation with Jiangsu Hengrui Pharmaceuticals since November 2019. In April 2019, Novaliq has founded Betaliq Inc., Tampa, USA in collaboration with BLP Management Group, LLC. Novaliq is a biopharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products. Our team of seasoned industry experts is driven by the single mission:.

Quick overview

Heidelberg, Germany

Founded in 2007

51-100 Employees

Medium-Sized

Additional information

Working industry

Pharmaceuticals

Type of company

Manufacturer

Ownership structure

Sole Proprietorship

Locations

2 Locations

Number of products

8 Products

Specialised areas

Advertising, Public Relations, and Related Services, Pharmaceutical, Scientific Research and Development Services, Medical and Diagnostic Laboratories, Health Care, Medical laboratories, Biotechnology, Medical research Advertising

Products & services of Novaliq

Novaliq offers a wide range of products and services

Product: CyclASol - Novaliq

Product

CyclASol - Novaliq

Go to product >

Product: Novatears+Omega-3 - Novaliq

Product

Novatears+Omega-3 - Novaliq

Go to product >

Product: NOV03 - Novaliq

Product

NOV03 - Novaliq

Go to product >

Product: Novatears - Novaliq

Product

Novatears - Novaliq

Go to product >

Product: Products - Novaliq

Product

Products - Novaliq

Go to product >

Product: Novel Drug Product Creation - Novaliq

Product

Novel Drug Product Creation - Novaliq

Go to product >

Product: EyeSol - Novaliq

Product

EyeSol - Novaliq

Go to product >

Product: Technology - Novaliq

Product

Technology - Novaliq

Go to product >

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

Germany


Overall risk estimation:

Very low


ESG country scores

The ESG Data of countries are based on public sources

Environment

A

Grade (A-E)

View details

Social

A

Grade (A-E)

View details

Governance

A

Grade (A-E)

View details

Headquarter of Novaliq

Novaliq operates in 2 countries around the world

City: Heidelberg

State: Baden-Württemberg

Country: Germany

Locations of Novaliq

Get an overview of the locations of Novaliq

Location

Country

State

City

Headquarter

Germany

Baden-Württemberg

Heidelberg

Novaliq Inc.

United States

Massachusetts

Cambridge

Frequently asked questions (FAQ) about Novaliq

Some frequent questions that have been asked about Novaliq

The company headquarter of Novaliq is located in Heidelberg, Baden-Württemberg, Germany. Novaliq has subsidiaries in United States

As of the latest available information Novaliq has around 51-100 employees worldwide.

Novaliq was founded in 2007

The company Novaliq has it's main focus in the industries of Pharmaceuticals

Based on the founding year and the amount of employees the company Novaliq seems to be a Medium-Sized at the current state. Note that over time that status can change

Competitors of Novaliq

Check out some interesting alternative companies to Novaliq

Novai's Logo

Novai

Reading, United Kingdom

11-50 Employees

2020

Novai is a finalist for the BIO Start-up Stadium Competition, 2021. Novai wins best Newcomer in the Clinical Trial Excellence Award 2020. Novai comes second in the finals for the Shenzhen Innovation & Entrepreneurship International Competition 2020. Expand scope of DARC biologic molecule as a targeted drug delivery vehicle which can overcome biological barriers known to impede drug delivery to eye and brain. By delivering DARC in a clearly outlined full-service model, we can boost efficiency, quickly determine efficacy and save you time and money.

NovalGen's Logo

NovalGen

London, United Kingdom

11-50 Employees

2019

NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond. Our mission is to create life-enhancing and curative new treatments for people with cancer. Headquartered in London, UK, NovalGen was formed in 2019. NovalGen is guided by our core set of values. The culture of NovalGen reflects these values and they help guide our decisions. NovalGen’s first pipeline product is a proprietary first in class bispecific T cell engager therapies that can safely harness the immune system to fight a wide range of cancers. We are changing the paradigm of cancer therapy with our immunotherapy technology.

Noyavision Pharmaceutical Group's Logo

Noyavision Pharmaceutical Group

Tehran, Iran

51-100 Employees

2006

Noyavision is a privately owned pharmaceutical company, established in 2006. Noyavision also focus on developing flexible and strong collaborations with a wide range of partners to strengthen its own capabilities. Noyavision is a privately owned pharmaceutical company, established in 2006, focused on developing, manufacturing and selling pharmaceutical and consumer healthcare products for patients. Noyavision Group provides a suite of pharmaceutical services that help clients transform scientific ideas into new treatments. Headquartered in Tehran, Iran, we are a specialty pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines and educating our large community of stakeholders about how we can help them for a healthier life. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, maximizing the value we create for our business and our diverse stakeholders.Our business is generated through products that are either acquired from our partners, co-developed by them, or individually developed by our R&D team. The basic principle in the quality policy of Noyavision is the notion that research and development, production, marketing and sales processes should be based upon internal and international quality standards GMP, GDP, GSP in order to meet customer requirements. Develop and deliver innovative pharmaceutical and nutraceutical product that helps the community to have a healthier life.

Novalis Biotechnology Incubation's Logo

Novalis Biotechnology Incubation

Ghent, Belgium

1-10 Employees

2018

Novalis Biotech is an early stage venture capital fund in life sciences. Novalis focuses on capital light business models and platform technology. Novalis Biotech is an early stage venture capital investor in life sciences. Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of diseases. As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences. We welcome innovative concepts in healthcare and aim to support their development already at the state of incorporation. Focus areas are: innovative research and manufacturing tools, bioinformatics, genomics, diagnostics and digital health.

Aquanova GmbH's Logo

Aquanova GmbH

Sankt Wendel, Germany

1-10 Employees

-

We are a FSSC 22000 (Food Safety) certified B2B manufacturer of liquid colloidal formulations called NovaSOL®, founded in 1995 and headquartered in Darmstadt/Germany close to Frankfurt. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect,will therefore be rejected. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement. The use and payment of all offered services are permitted - if and so far technically possible and reasonable - without specification of any personal data or under specification of anonymized data or an alias. Data Protection is very important for AQUANOVA AG. The recording ends as soon as the respective session is ended. They serve to make the Internet offer as a whole more user-friendly and effective, and therefore more convenient for the user. The provider is Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland.

Healome Therapeutics's Logo

Healome Therapeutics

Birmingham, United Kingdom

1-10 Employees

2021

Healome Therapeutics is a clinical stage company developing treatments for eye conditions, with a particular interest in ocular surface diseases and injuries.​. We aim to create products that can help patients and healthcare care providers to obtain transformative clinical and quality of life outcomes through the safest, simplest, and most scalable approaches possible. Our current products under development are based on a proprietary eye drop technology offering combined drug retention, lubrication and protection at the ocular surface.​. While we strive to transform eye care over the longer-term, we are committed to improving the field in the near-term as well. Better healthcare by deploying ‘better medicine’ at scale in a way that enables healthcare providers and people to effectively manage the growing and evolving eye health challenges around the world.